Two-year Therapeutic Effect of PCI in 1911 Patients with Multivessel Coronary Artery Disease

HAN Ya-ling,LI Cheng-yang,WANG Xiao-zeng,JING Quan-min,WANG Shou-li,MA Ying-yan
DOI: https://doi.org/10.3969/j.issn.1009-7236.2007.03.016
2007-01-01
Abstract:AIM To retrospectively investigate the long-term therapeutic effect of percutaneous coronary intervention (PCI) on revascularization in patients with multivessel coronary artery disease (MVD). METHODS From June 1995 to December 2003, a total of 2028 patients with MVD were treated by PCI and the rates of angina recurrence, angiographic restenosis and major adverse cardiac events (MACE) were retrospectively analyzed. RESULTS Among the 2028 patients, complete revascularization rate was 86.2% (1748/2028). The total in-hospital mortality rate was 1.3% (26/2028) and 2002 were discharged after treatment, of whom 1911 patients (95.5%) were followed up for 24 months. The rates of angina recurrence, angiographic restenosis and MACE were 10.7%, 14.6% and 25.4%, respectively. Of the 1911 cases, 1754 patients had been treated by bare metal stent(BMS)and 157 patients treated by drug-eluting stent (DES). Although the patients treated by DES had more risk factors and more complex coronary lesions [61.8% with unstable angina, 41.4% with diabetes, 37.6% with chronic total occlusion (CTO) and 58.0% with triple-vessel disease] , the post-PCI rates of angina recurrence, angiographic restenosis and MACE were significantly lower than those in patients treated by BMS (4.5% vs 11.2%, 3.2% vs 15.7%, 8.9% vs 26.9%, P0.01). CONCLUSION The PCI revascularization is an effective treatment in patients with MVD, but the patients treated with BMS may have relatively higher MACE rate. DES has better long-term therapeutic effect in patients with MVD.
What problem does this paper attempt to address?